Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Microscope in a BioEscalator Lab


Strategic collaboration announced between Enara Bio and Boehringer Ingelheim

The partnership deal, worth over €876M, will enable Enara Bio to lead the discovery and validation of Dark Antigens to target lung and gastrointestinal cancers.

Theolytics raises $6.8M to advance oncolytic viral therapy against cancer

Theolytics Series A funding round was co-led by Epidarex Capital and Taiho Ventures LLC with participation from existing investor, Oxford Sciences Innovation (OSI).

Enara Bio adds further world-class cell therapy and immuno-oncology expertise to senior leadership team and Scientific Advisory Board

These appointments will provide experienced industry leadership and perspective to support Enara Bio's rapid growth and development in key strategic areas.

Upcoming Events

Advanced Therapy Showcase - Tokyo

Thursday, 21 January 2021 to Wednesday, 17 February 2021

Life Science Innovation Network Japan (Link-J) launches it’s first Advanced Therapy Showcase event featuring live-streamed company presentations, on-demand pitches and pre-arranged 1-1 business partnering open until the 17th of February.

Advanced Therapies Connect

Tuesday, 26 January 2021 to Wednesday, 27 January 2021

Making new connections is vital to helping biotechs continue on their commercialisation journey. Advanced Therapies Connect is a unique virtual networking and learning experience as part of MEDCITYs partnership with Phacilitate.

Thought Leadership and Content Strategy

Tuesday, 26 January 2021, 10am to 11am

Change perceptions and generate leads in health & life sciences

Meet the clinician – Cancer day

Tuesday, 26 January 2021, 4pm to 6pm

TheHill Oxford and Oxford AHSN are holding a special two-part event for innovators and pharmaceutical companies developing innovation in cancer care and treatment.

BioEscalator Team
Photograph of the BioEscalator building and adjoining carpark, taken from the top of the Kennedy building © BioEscalator Oxford